PlusPedia wird derzeit technisch modernisiert. Aktuell laufen Wartungsarbeiten. Für etwaige Unannehmlichkeiten bitten wir um Entschuldigung; es sind aber alle Artikel zugänglich und Sie können PlusPedia genauso nutzen wie immer.
Neue User bitte dringend diese Hinweise lesen:
Anmeldung - E-Mail-Adresse Neue Benutzer benötigen ab sofort eine gültige Email-Adresse. Wenn keine Email ankommt, meldet Euch bitte unter NewU25@PlusPedia.de.
Hinweis zur Passwortsicherheit:
Bitte nutzen Sie Ihr PlusPedia-Passwort nur bei PlusPedia.
Wenn Sie Ihr PlusPedia-Passwort andernorts nutzen, ändern Sie es bitte DORT bis unsere Modernisierung abgeschlossen ist.
Überall wo es sensibel, sollte man generell immer unterschiedliche Passworte verwenden! Das gilt hier und im gesamten Internet.
Aus Gründen der Sicherheit (PlusPedia hatte bis 24.07.2025 kein SSL | https://)
Bei PlusPedia sind Sie sicher: – Wir verarbeiten keine personenbezogenen Daten, erlauben umfassend anonyme Mitarbeit und erfüllen die Datenschutz-Grundverordnung (DSGVO) vollumfänglich. Es haftet der Vorsitzende des Trägervereins.
PlusPedia blüht wieder auf als freundliches deutsches Lexikon.
Wir haben auf die neue Version 1.43.3 aktualisiert.
Wir haben SSL aktiviert.
Hier geht es zu den aktuellen Aktuelle Ereignissen
H63D Syndrome Research Consortium: Unterschied zwischen den Versionen
K Link |
Vergessen gehabt einzufügen. |
||
| (5 dazwischenliegende Versionen desselben Benutzers werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
The '''International H63D Syndrome Research Consortium''' is a network of 35 scientists representing twelve [[Staat|nations]]. It is | The '''International H63D Syndrome Research Consortium''' is a network of more than 35 scientists representing twelve [[Staat|nations]]. It is a non-profit and financially independent organization for research into all types of [[Eisen|iron]] storage diseases. | ||
== History == | == History == | ||
The consortium was founded in 2019 in response to the irritation of [[Asien|Asian]] scientists in particular that their studies and research findings were ignored in Western [[Europa|Europe]] and [[USA|North America]]. As a result, the H63D Syndrome Research Consortium was founded through which the scientists can address the public directly. Modern communication tools such as "social media" are used intensively. | The consortium was founded in 2019 in response to the irritation of [[Asien|Asian]] scientists, in particular that their studies and research findings were ignored in Western [[Europa|Europe]] and [[USA|North America]]. As a result, the H63D Syndrome Research Consortium was founded through which the scientists can address the public directly. Modern communication tools such as "social media" are used intensively. | ||
== Research & Awareness == | == Research & Awareness == | ||
Research is primarily | Research is primarily done on the HFE mutation in gene H63D, since this location is not focussed on Europe and North America as C282Y is. What is more, it can rarely trigger hemochromatosis but more frequently the H63D syndrome (NTBI iron poisoning) which is in the need of awareness within the medical community. However, the work of the consortium is not limited to this mutation. The common variant C282Y and many others are also the subject of the consortium's research. Another main task is to raise awareness for the more rare iron storage disorders and the dangers of non-transferrin-bound-iron (NTBI iron). | ||
At present, the following experts are members of the consortium: | At present, the following experts are members of the consortium: | ||
*Dr. Marianne Kaufmann | *Dr. Marianne Kaufmann | ||
*Manuel H.G. Ronquillo, MD | |||
*Dr. Sven Sørensen | *Dr. Sven Sørensen | ||
*A.K. Tripathi, PhD | |||
*Avi Feldman, PhD | *Avi Feldman, PhD | ||
*Dr. I. Slotki, M.Sc. | |||
*Jacob S. Adams, PhD | *Jacob S. Adams, PhD | ||
*A.M Gardeck, MD | |||
*Riku Honda, PhD | *Riku Honda, PhD | ||
*Dr. Anastasios Papadopoulos | *Dr. Anastasios Papadopoulos | ||
| Zeile 22: | Zeile 26: | ||
*John M. Smith, PhD | *John M. Smith, PhD | ||
*Dipl.-Biol. Thomas Berg | *Dipl.-Biol. Thomas Berg | ||
*and many more | |||
== Links == | == Links == | ||
| Zeile 27: | Zeile 32: | ||
*[http://www.irondisorders.org/Websites/idi/files/Content/854268/ST%20H63D%20APR%202010.pdf Iron Disorders Institute, 2010] | *[http://www.irondisorders.org/Websites/idi/files/Content/854268/ST%20H63D%20APR%202010.pdf Iron Disorders Institute, 2010] | ||
*[https://www.facebook.com/IronDisordersResearch The consortium’s social media page] | *[https://www.facebook.com/IronDisordersResearch The consortium’s social media page] | ||
*m.me/IronDisordersResearch (Contact for laypeople) | |||
*h63d@groupmail.com (Contact for physicians and scientists only) | |||
[[Kategorie:Gesundheit]] | [[Kategorie:Gesundheit]] | ||
[[Kategorie:Wissenschaft]] | [[Kategorie:Wissenschaft]] | ||
Aktuelle Version vom 2. Februar 2020, 13:09 Uhr
The International H63D Syndrome Research Consortium is a network of more than 35 scientists representing twelve nations. It is a non-profit and financially independent organization for research into all types of iron storage diseases.
History
The consortium was founded in 2019 in response to the irritation of Asian scientists, in particular that their studies and research findings were ignored in Western Europe and North America. As a result, the H63D Syndrome Research Consortium was founded through which the scientists can address the public directly. Modern communication tools such as "social media" are used intensively.
Research & Awareness
Research is primarily done on the HFE mutation in gene H63D, since this location is not focussed on Europe and North America as C282Y is. What is more, it can rarely trigger hemochromatosis but more frequently the H63D syndrome (NTBI iron poisoning) which is in the need of awareness within the medical community. However, the work of the consortium is not limited to this mutation. The common variant C282Y and many others are also the subject of the consortium's research. Another main task is to raise awareness for the more rare iron storage disorders and the dangers of non-transferrin-bound-iron (NTBI iron).
At present, the following experts are members of the consortium:
- Dr. Marianne Kaufmann
- Manuel H.G. Ronquillo, MD
- Dr. Sven Sørensen
- A.K. Tripathi, PhD
- Avi Feldman, PhD
- Dr. I. Slotki, M.Sc.
- Jacob S. Adams, PhD
- A.M Gardeck, MD
- Riku Honda, PhD
- Dr. Anastasios Papadopoulos
- Dr. Moshgan Mohammadi
- Dr. Boris Dimitrov
- Dr. Ali Akbar Hosseini
- Dr. Yashida Akko
- Silas E. Frank, M.Sc.
- John M. Smith, PhD
- Dipl.-Biol. Thomas Berg
- and many more
Links
- Consensus Paper 2019
- Iron Disorders Institute, 2010
- The consortium’s social media page
- m.me/IronDisordersResearch (Contact for laypeople)
- h63d@groupmail.com (Contact for physicians and scientists only)